These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 26243202)
1. American Association of Cancer Research Showcases Immunotherapy Advances. Brower V J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26243202 [No Abstract] [Full Text] [Related]
7. Immuno-oncology drugs jostle for first-line setting. Mullard A Nat Rev Drug Discov; 2016 Nov; 15(11):738. PubMed ID: 27807351 [No Abstract] [Full Text] [Related]
8. Programmed death protein 1 inhibitors making inroads in multiple cancers. Brower V J Natl Cancer Inst; 2015 May; 107(5):. PubMed ID: 25957444 [No Abstract] [Full Text] [Related]
9. Pembrolizumab joins the anti-PD-1 armamentarium in the treatment of melanoma. Hersey P; Gowrishankar K Future Oncol; 2015; 11(1):133-40. PubMed ID: 25572788 [TBL] [Abstract][Full Text] [Related]
10. Current Perspectives in Immunotherapy for Non-Small Cell Lung Cancer. Garon EB Semin Oncol; 2015 Oct; 42 Suppl 2():S11-8. PubMed ID: 26477470 [TBL] [Abstract][Full Text] [Related]
11. Advances in Immuno-Oncology: Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer-Introduction. Socinski MA Semin Oncol; 2015 Oct; 42 Suppl 2():S1-2. PubMed ID: 26477469 [No Abstract] [Full Text] [Related]
12. Immune modulation in cancer with antibodies. Page DB; Postow MA; Callahan MK; Allison JP; Wolchok JD Annu Rev Med; 2014; 65():185-202. PubMed ID: 24188664 [TBL] [Abstract][Full Text] [Related]